VIRAMUNE cpr 200 mg 14 pce
7680543930175
CH-54393
J05AG01
08.03.0.
1 / 3
google
Details
- Product number
- 5439301
- CPT
- -
- Packaging group
- 14
- Unit
- Tablette(n)
- Composition
- nevirapinum 200 mg, cellulosum microcristallinum, lactosum monohydricum 318 mg, povidonum K 25, carboxymethylamylum natricum A corresp. natrium 714 µg, silica colloidalis anhydrica, magnesii stearas pro compresso.
Articles (1)
Viramune, Tabletten
Tabletten
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
318.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
714.0 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 67.10
Specialties list
Yes
Generic
No
SL addition date:
01/03/2012
Authorization holder
Boehringer Ingelheim (Schweiz) GmbH
4057 Basel
Authorization information
- Swissmedic authorization number
- 54393
- Drug name
- Viramune, Tabletten
- Galenic form
- TAB
- ATC Code
- J05AG01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/12/1997
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VIRAMUNE cpr 200 mg 14 pce
- Description (DE)
- VIRAMUNE Tabl 200 mg 14 Stk
- Market launch
- 23/12/1997
- Narcotic (BTM)
- No